Smith, Salley & Associates Senseonics Holdings, Inc. Transaction History
Smith, Salley & Associates
- $1.84 Billion
- Q3 2025
A detailed history of Smith, Salley & Associates transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Smith, Salley & Associates holds 61,000 shares of SENS stock, worth $381,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,000
Previous 55,000
10.91%
Holding current value
$381,860
Previous $26,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SENS
# of Institutions
126Shares Held
110MCall Options Held
309KPut Options Held
372K-
Vanguard Group Inc Valley Forge, PA34.2MShares$214 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN18MShares$113 Million0.95% of portfolio
-
Geode Capital Management, LLC Boston, MA8.98MShares$56.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$52.1 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA5MShares$31.3 Million0.08% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $2.91B
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...